|
|
Pancreatic
lesions |
Gall bladder
lesions |
Total no of
cases |
28 |
18 |
|
Age of
pateints (in years) |
20-39 years |
3 |
0 |
40-60years |
14 |
10 |
|
> 60 years |
12 |
8 |
|
Sex of
pateints |
Male |
18 |
11 |
Female |
10 |
7 |
Sr no |
Types of cases |
Number |
1 |
Acute
pancreatitis |
2 |
2 |
Mucinous
cystadenoma of pancreas |
1 |
3 |
Serous
cystadenoma of pancreas |
1 |
4 |
Ductal
adenocarcinoma of pancreas |
24 |
5 |
Choledocholithoasis/gall
stones |
3 |
6 |
Gall
bladder carcinoma/ cholangiocarcinoma |
15 |
Sr no |
Clinopathological factors |
Number |
Ca 19-9 (mean) |
Ca 19-9 (median) |
1 |
Age :
(n=28) 20- 39 yrs 40-59 yrs >
60 yrs |
03
(10.7%) 14
(50.1%) 11(39.28%) |
289.63 232.03 350.20 |
250.9 178.8 350.2 |
2 |
Sex: (n=28) Male Female |
18
(64.28%) 10
(35.71%) |
395.85 320.26 |
218.85 198.20 |
3 |
Location: (n=26) Head
of pancreas Body
and tail |
21
(80.76 %) 05
(19.23%) |
445.08 173.18 |
253.6 193.8 |
5 |
Neoplasm: (n=26) Benign Malignant |
02
(14.28%) 24
(85.71%) |
62.35 420.35 |
62 252.25 |
7 |
Staging: (n=24) Stage
i Stage
iia Stage
iib Stage
iii Stage
iv |
1
(4.16%) 5
(20.83%) 5
(20.83%) 5
(20.83%) 8
(33.33%) |
11 214.78 172.70 337.6 806.48 |
11 186.8 193.8 282.8 627.2 |
8 |
Metastasis: (n=24) Only
lymph node Only
distant organs Both
ln and distant organ metastasis No
metastasis |
09
(37.5 %) 04
(16.66%) 04(16.66%) 07(29.13%) |
617.14 806.71 1339 183.92 |
362.2 627.2 1402.2 186.8 |
Sr no |
Clinopathological
factors |
Number |
Ca 19-9 (mean) |
Ca
19-9(median) |
1 |
Age :
(n=18) 20- 39 yrs 40-59 yrs >
60 yrs |
0 10(55.55%) 08(44.44%) |
00 161.27 301.225 |
00 86.6 213.05 |
2 |
Sex: (n=18) Male Female |
11(61.11%) 07(38.88%) |
316.45 166.32 |
40 120 |
3 |
Neoplasm: (n=18) Benign Malignant |
03(16.66%) 15(83.33%) |
28.66 254.43 |
23 123.8 |
5 |
Staging: (n=15) Stage
i Stage
ii Stage
iiia Stage
iiib Stage
iva Stage
ivb |
00 04(26.66%) 05(33.33%) 03(20%) 00 03(20%) |
217.87 276.2 178.16 - 383.16 |
109.45 120 118.2 - 302.3 |
6 |
Metastasis:
(n=15) only lymph node Only
distant organs Both
ln and other organ metastasis No
metastasis |
03(20%) 01(6.6%) 02(13.33%) 09(60%) |
276.34 383.16 423.6 283.6 |
123.8 302.2 423.6 120 |
Ca 19-9 level |
Median survival in pancreatic
carcinoma (months) |
Median survival in cholangiocarcinoma
(months) |
<37 u/ml |
28
|
-- |
37-
<200u/ml |
18
|
23.25 |
>200 u /ml |
6
|
10.25 |
Ca 19-9 level |
Median survival in pancreatic
carcinoma (months) |
Median survival in cholangiocarcinoma
(months) |
>50% decrease in level |
18
|
20 |
<50% decrease in level |
6
|
13.5 |
|
Sensitivity |
Specificity |
Positive Predictive value |
Negative
predictive Value |
Pancreatic Carcinoma |
87.50% |
50.00% |
91.30% |
40.00% |
Cholangio Carcinoma |
80% |
66.67% |
92.31% |
40.00% |